Year: 2022

ARKO-CORP-

ARKO Corp. Announces Agreement to Acquire all Assets of Transit Energy Group, a Large Privately Held Portfolio in the Southeast with Approximately 350 Sites Across Retail and Wholesale

BIO-key-International-Inc-1-1

BIO-key and Multipoint GROUP Join Forces to Promote Cybersecurity and Identity Solutions to High-Growth Global Markets in Europe and the Middle East

Partnership includes distribution, pre-sales, training, and full support to resellers and customers WALL, N.J. and MADRID, Spain, Sept. 12, 2022...

Seagen_Logo_RGB

Seagen, Astellas and Merck Announce Results of Clinical Trial Investigating PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) and PADCEV as Monotherapy in First-Line Advanced Urothelial Cancer

– Results demonstrated a 64.5% confirmed objective response rate in patients treated with investigational combination of enfortumab vedotin and pembrolizumab...

AnHeart_Logo_2_28129_28129

AnHeart Therapeutics and NewG Lab Therapeutics Receive Orphan Drug Designation in Korea for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer

NEW YORK & SEOUL, South Korea--(BUSINESS WIRE)--#BTD--AnHeart Therapeutics and NewG Lab Therapeutics, a subsidiary of NewG Lab Pharma, announced that...